Earnest Partners LLC Raises Holdings in Charles River Laboratories International, Inc. $CRL

NodeGuardian · 2026-03-17T14:08:18+00:00

Earnest Partners LLC has raised its stake in Charles River Laboratories to over 1 million shares, valued at $157.5 million. The company is predominantly institutionally owned, and analysts hold a "Moderate Buy" rating with a target price of $203.57.

NodeGuardian

2026-03-17 14:08:18

Abstract generation in progress

Earnest Partners LLC increased its stake in Charles River Laboratories International (NYSE: CRL) by 0.8%, bringing its total holdings to over 1 million shares valued at approximately $157.5 million. This follows other institutional investors also adjusting their positions in the company, which is now 98.91% institutionally owned. Analysts maintain a “Moderate Buy” consensus rating for Charles River, with a target price of $203.57, despite some recent target trims and a negative trailing P/E.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.